Oligovax
  • Home
  • Shop
  • Biosci™ Lymphocyte Separation Tube for Human Peripheral Blood
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • 0
  • +33 1 43 25 01 50
  • Sign in
  • Contact Us
Oligovax
  • 0
  • 0
    • Home
    • Shop
    • Biosci™ Lymphocyte Separation Tube for Human Peripheral Blood
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +33 1 43 25 01 50
  • Sign in
  • Contact Us
Lessons
Share Exit Fullscreen Back to course
Pathogen co-infection involving HIV-1, tuberculosis (TB), malaria, and hepatitis C virus (HCV)
    • Chapter 1: Introduction of Pathogen co-infection
      • Join this Course to access resources
      • Quiz
    • Chapter 2: Epidemiology and Global Burden
      • Join this Course to access resources
      • Quiz
    • Chapter 3 : Interaction between Pathogens
      • Join this Course to access resources
      • Quiz

Oligovax SAS

Operator of a biopharmaceutical company intended to provide therapies for cancer. The company develops drug substances consisting of synthetic oligonucleotides (ODNs) containing cytosine-guanine dinucleotide (CpG) motifs that have optimized immunostimulating properties, helping healthcare practitioners to cure patients suffering from cancer.

Oligovax SAS

Gentaur Group

  • 9 Rue Lagrange, 75005 Paris, France.
  • +33 1 43 25 01 50
  • info@oligovax.com
Follow us
Copyright © Oligovax